Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marex GroupMRX +5.57%17 3-Year EBITDA Growth Rate is 55.20% as of Jun. 2026, which is 27% below its 10-year median of 76.00. GuruFocus rates MRX with a GF Score™ of 17/100. The stock has 8 warning signs investors should review. Among 509 Capital Markets companies, Marex Group ranks better than 82.51% on this metric.
During the past 12 months, Marex Group's average EBITDA Per Share Growth Rate was 41.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 55.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Marex Group was 96.80% per year. The lowest was 55.20% per year. And the median was 76.00% per year.
Marex Group (NAS:MRX) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Marex Group 3-Year EBITDA Growth Rate Related Terms
MRX vs PIPR, MC, MKTX: 3-Year EBITDA Growth Rate Comparison
For the Capital Markets subindustry, Marex Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Marex Group 3-Year EBITDA Growth Rate vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Marex Group's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Marex Group's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 55.20% mean?
Marex Group (MRX) has a 3-Year EBITDA Growth Rate of 55.20% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Marex Group and its competitors. This is 27% below median its historical median of 76.00. Over the past decade, Marex Group's 3-Year EBITDA Growth Rate has ranged from 55.20 to 96.80. According to the industry distribution chart, Marex Group ranks #89 out of 509 companies in the Capital Markets industry, placing it in the top 17.5%.
Is Marex Group's 3-Year EBITDA Growth Rate too high?
Marex Group's current 3-Year EBITDA Growth Rate of 55.20% is 27% below median its 10-year median of 76.00. Over the past 10 years, this metric has ranged from a low of 55.20 to a high of 96.80. The Capital Markets industry median 3-Year EBITDA Growth Rate is 14.80. Marex Group's value of 55.20% is 273% above this industry median. Based on the distribution chart, Marex Group ranks #89 out of 509 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, Marex Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Marex Group's 3-Year EBITDA Growth Rate compare to PIPR and MC?
According to the Capital Markets industry distribution chart, Marex Group ranks #89 out of 509 companies for 3-Year EBITDA Growth Rate. This places Marex Group in the top 18% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 14.80. Marex Group's value of 55.20% is 273% above this benchmark. Historically, Marex Group's own 3-Year EBITDA Growth Rate has ranged from 55.20 to 96.80 over the past decade. While the company's 10-year median is 76.00 vs. the industry median of 14.80, Marex Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Capital Markets company?
The median 3-Year EBITDA Growth Rate among Capital Markets companies is 14.80, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Marex Group's current 3-Year EBITDA Growth Rate of 55.20% is 273% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Marex Group and its competitors. For the Capital Markets industry, the median 3-Year EBITDA Growth Rate is 14.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Marex Group's current 3-Year EBITDA Growth Rate is 55.20%, which is 27% below median its own 10-year median of 76.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marex Group stock overvalued right now?
Marex Group (MRX) has a current 3-Year EBITDA Growth Rate of 55.20%. The current 3-Year EBITDA Growth Rate is 55.20%, which is 27% below median its 10-year median of 76.00 and 273% above the Capital Markets industry median of 14.80. Marex Group's overall GF Score™ is 17/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Marex Group (MRX), the current 3-Year EBITDA Growth Rate is 55.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Marex Group PLC is a financial services platform, providing liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets. The Group's operating segments are: Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and Corporate. Maximum revenue is generated from the Agency and Execution segment, which offers liquidity and execution services to clients mainly in the energy and financial securities markets by connecting buyers and sellers in the energy markets, offering liquidity and risk management solutions for financial markets, and providing clearing, custody, capital introduction, portfolio financing, and outsourced trading services. Geographically, the Group generates maximum revenue from the United States.
17GF Score
Get the complete analysis for MRX
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRX has been successfully added to your 
